These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 24246421)

  • 1. Preferred features of a fluorine-19 MRI probe for amyloid detection in the brain.
    Yanagisawa D; Taguchi H; Ibrahim NF; Morikawa S; Shiino A; Inubushi T; Hirao K; Shirai N; Sogabe T; Tooyama I
    J Alzheimers Dis; 2014; 39(3):617-31. PubMed ID: 24246421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 19F and 1H MRI detection of amyloid beta plaques in vivo.
    Higuchi M; Iwata N; Matsuba Y; Sato K; Sasamoto K; Saido TC
    Nat Neurosci; 2005 Apr; 8(4):527-33. PubMed ID: 15768036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Metal-Free Method for Producing MRI Contrast at Amyloid-β.
    Hilt S; Tang T; Walton JH; Budamagunta M; Maezawa I; Kálai T; Hideg K; Singh V; Wulff H; Gong Q; Jin LW; Louie A; Voss JC
    J Alzheimers Dis; 2017; 55(4):1667-1681. PubMed ID: 27911291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid imaging using fluorine-19 magnetic resonance imaging ((19)F-MRI).
    Tooyama I; Yanagisawa D; Taguchi H; Kato T; Hirao K; Shirai N; Sogabe T; Ibrahim NF; Inubushi T; Morikawa S
    Ageing Res Rev; 2016 Sep; 30():85-94. PubMed ID: 26772439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo detection of amyloid β deposition using ¹⁹F magnetic resonance imaging with a ¹⁹F-containing curcumin derivative in a mouse model of Alzheimer's disease.
    Yanagisawa D; Amatsubo T; Morikawa S; Taguchi H; Urushitani M; Shirai N; Hirao K; Shiino A; Inubushi T; Tooyama I
    Neuroscience; 2011 Jun; 184():120-7. PubMed ID: 21497641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AZD2184: a radioligand for sensitive detection of beta-amyloid deposits.
    Johnson AE; Jeppsson F; Sandell J; Wensbo D; Neelissen JA; Juréus A; Ström P; Norman H; Farde L; Svensson SP
    J Neurochem; 2009 Mar; 108(5):1177-86. PubMed ID: 19141073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging of amyloid plaques using hollow manganese oxide nanoparticles conjugated with antibody aβ1-40 in a transgenic mouse model.
    Kim JH; Ha TL; Im GH; Yang J; Seo SW; Lee IS; Lee JH
    Neuroreport; 2013 Jan; 24(1):16-21. PubMed ID: 23168564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. F-18 Polyethyleneglycol stilbenes as PET imaging agents targeting Abeta aggregates in the brain.
    Zhang W; Oya S; Kung MP; Hou C; Maier DL; Kung HF
    Nucl Med Biol; 2005 Nov; 32(8):799-809. PubMed ID: 16253804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI assessment of neuropathology in a transgenic mouse model of Alzheimer's disease.
    Helpern JA; Lee SP; Falangola MF; Dyakin VV; Bogart A; Ardekani B; Duff K; Branch C; Wisniewski T; de Leon MJ; Wolf O; O'Shea J; Nixon RA
    Magn Reson Med; 2004 Apr; 51(4):794-8. PubMed ID: 15065253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel 18F-labeled pyridyl benzofuran derivative for imaging of β-amyloid plaques in Alzheimer's brains.
    Cheng Y; Ono M; Kimura H; Kagawa S; Nishii R; Saji H
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6141-4. PubMed ID: 20817524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in the brain and plasma Aβ peptide levels with age and its relationship with cognitive impairment in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Izco M; Martínez P; Corrales A; Fandos N; García S; Insua D; Montañes M; Pérez-Grijalba V; Rueda N; Vidal V; Martínez-Cué C; Pesini P; Sarasa M
    Neuroscience; 2014 Mar; 263():269-79. PubMed ID: 24447596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo SPECT imaging of amyloid-β deposition with radioiodinated imidazo[1,2-a]pyridine derivative DRM106 in a mouse model of Alzheimer's disease.
    Chen CJ; Bando K; Ashino H; Taguchi K; Shiraishi H; Shima K; Fujimoto O; Kitamura C; Matsushima S; Uchida K; Nakahara Y; Kasahara H; Minamizawa T; Jiang C; Zhang MR; Ono M; Tokunaga M; Suhara T; Higuchi M; Yamada K; Ji B
    J Nucl Med; 2015 Jan; 56(1):120-6. PubMed ID: 25476539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Butyrylcholinesterase-knockout reduces brain deposition of fibrillar β-amyloid in an Alzheimer mouse model.
    Reid GA; Darvesh S
    Neuroscience; 2015 Jul; 298():424-35. PubMed ID: 25931333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal monitoring of sex-related in vivo metabolic changes in the brain of Alzheimer's disease transgenic mouse using magnetic resonance spectroscopy.
    van Duijn S; Nabuurs RJ; van Duinen SG; Natté R; van Buchem MA; Alia A
    J Alzheimers Dis; 2013; 34(4):1051-9. PubMed ID: 23321522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging.
    Wadghiri YZ; Sigurdsson EM; Sadowski M; Elliott JI; Li Y; Scholtzova H; Tang CY; Aguinaldo G; Pappolla M; Duff K; Wisniewski T; Turnbull DH
    Magn Reson Med; 2003 Aug; 50(2):293-302. PubMed ID: 12876705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET neuroimaging studies of [(18)F]CABS13 in a double transgenic mouse model of Alzheimer's disease and nonhuman primates.
    Liang SH; Holland JP; Stephenson NA; Kassenbrock A; Rotstein BH; Daignault CP; Lewis R; Collier L; Hooker JM; Vasdev N
    ACS Chem Neurosci; 2015 Apr; 6(4):535-41. PubMed ID: 25776827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High order W02-reactive stable oligomers of amyloid-β are produced in vivo and in vitro via dialysis and filtration of synthetic amyloid-β monomer.
    Robb E; Perez K; Hung LW; Masters CL; Barnham KJ; Cherny RA; Bush AI; Adlard PA; Finkelstein DI
    J Alzheimers Dis; 2015; 44(1):69-78. PubMed ID: 25182735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Jeon S; Bose S; Hur J; Jun K; Kim YK; Cho KS; Koo BS
    J Ethnopharmacol; 2011 Sep; 137(1):783-9. PubMed ID: 21762767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-labeled flavones for in vivo imaging of beta-amyloid plaques in Alzheimer's brains.
    Ono M; Watanabe R; Kawashima H; Kawai T; Watanabe H; Haratake M; Saji H; Nakayama M
    Bioorg Med Chem; 2009 Mar; 17(5):2069-76. PubMed ID: 19201614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.